‹ Back
LL-37, Cathelicidin
In people
When LL-37 rises in a person, the skin and mucous surfaces hold microbes back better, and stubborn wounds begin to close as new blood vessels grow into them. People using it for chronic infections describe fewer flares and faster clearing. People with low vitamin D make less LL-37, and raising vitamin D raises it. At the injection site, redness and a mild itch are common for a day, since LL-37 is an active immune signal.
Sources
Read the original sources
- An angiogenic role for the human peptide antibiotic LL-37/hCAP-18 (Abstract · checked 2026-10-13)
- LL-37 membrane and host-cell biology (Abstract · checked 2026-10-13)
- Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3 (Abstract · checked 2026-10-13)